DISOPHROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Disophrol, and what generic alternatives are available?
Disophrol is a drug marketed by Schering Plough and Schering and is included in two NDAs.
The generic ingredient in DISOPHROL is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DISOPHROL?
- What are the global sales for DISOPHROL?
- What is Average Wholesale Price for DISOPHROL?
Summary for DISOPHROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| DailyMed Link: | DISOPHROL at DailyMed |
US Patents and Regulatory Information for DISOPHROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering Plough | DISOPHROL | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 013483-004 | Sep 13, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | DISOPHROL | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET;ORAL | 012394-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
